Literature DB >> 3663454

Tribulin output in neurological disorders.

A Clow, V Glover, M Sandler, R Elwes, E H Reynolds.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3663454      PMCID: PMC1386267          DOI: 10.1111/j.1365-2125.1987.tb03190.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  8 in total

1.  Distribution of endogenous benzodiazepine receptor ligand-monoamine oxidase inhibitory activity (tribulin) in tissues.

Authors:  I Armando; V Glover; M Sandler
Journal:  Life Sci       Date:  1986-06-02       Impact factor: 5.037

2.  The influence of seizure type and medication on psychiatric symptoms in epileptic patients.

Authors:  S W Brown; M E McGowan; E H Reynolds
Journal:  Br J Psychiatry       Date:  1986-03       Impact factor: 9.319

3.  Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor.

Authors:  V Glover; S K Bhattacharya; M Sandler; S E File
Journal:  Nature       Date:  1981-07-23       Impact factor: 49.962

4.  New endogenous benzodiazepine receptor ligand in human urine: identity with endogenous monoamine oxidase inhibitor?

Authors:  A Clow; V Glover; I Armando; M Sandler
Journal:  Life Sci       Date:  1983-08-22       Impact factor: 5.037

5.  Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol.

Authors:  S K Bhattacharya; V Glover; M Sandler; A Clow; A Topham; M Bernadt; R Murray
Journal:  Biol Psychiatry       Date:  1982-07       Impact factor: 13.382

6.  A monoamine oxidase inhibitor in human urine.

Authors:  V Glover; M A Reveley; M Sandler
Journal:  Biochem Pharmacol       Date:  1980-02       Impact factor: 5.858

7.  Psychiatric illness in inpatients with neurological disorders: patients' views on discussion of emotional problems with neurologists.

Authors:  K W Bridges; D P Goldberg
Journal:  Br Med J (Clin Res Ed)       Date:  1984-09-15

8.  Urinary MAO inhibitor in psychiatric illness.

Authors:  H Petursson; M A Reveley; V Glover; M Sandler
Journal:  Psychiatry Res       Date:  1981-12       Impact factor: 3.222

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.